We report that IFN-α skews antigen presentation in favor of HLA-B-restricted peptides, including both conventional and alternative antigens, which are recognized by islet-infiltrating CD8+ T cells of T1D patients. The gene discussed is CD8A; the disease is type 1 diabetes mellitus.